Eco R1 Capital, LLC Atea Pharmaceuticals, Inc. Transaction History
Eco R1 Capital, LLC
- $2.14 Billion
- Q4 2024
A detailed history of Eco R1 Capital, LLC transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Eco R1 Capital, LLC holds 3,341,653 shares of AVIR stock, worth $10.3 Million. This represents 0.52% of its overall portfolio holdings.
Number of Shares
3,341,653
Previous 5,441,896
38.59%
Holding current value
$10.3 Million
Previous $18.2 Million
38.6%
% of portfolio
0.52%
Previous 0.79%
Shares
7 transactions
Others Institutions Holding AVIR
# of Institutions
112Shares Held
50.9MCall Options Held
7.6KPut Options Held
38.7K-
Black Rock Inc. New York, NY9.12MShares$28.1 Million0.0% of portfolio
-
Bml Capital Management, LLC Zionsville, IN7.61MShares$23.4 Million15.83% of portfolio
-
Tang Capital Management LLC San Diego, CA4.79MShares$14.7 Million1.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.67MShares$14.4 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.49MShares$7.66 Million2.25% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $256M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...